Sponsor study identifier
interventional
58
1 country
3
Study Start
November 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2009
Actual (reported)Study Completion
July 2009
Actual (reported)Compare the glycemic and insulinemic responses of a standard nutritional product with two diabetes-specific nutritional products in patients with type 2 diabetes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2008
Date type not reportedThis date has not been verified as actual or estimated.
November 23, 2008
Actual (reported)November 25, 2008
Actual (reported)February 2009
Actual (reported)July 2009
Actual (reported)To compare the postprandial glycemic response of patients with type 2 diabetes consuming single servings of a standard liquid nutrition product and two diabetes-specific liquid nutrition products.
Three crossover periods
To compare the postprandial insulinemic response of patients with type 2 diabetes consuming single servings of a standard liquid nutrition product and two diabetes-specific liquid nutrition products.
Three crossover periods
Standard nutritional product not specific for diabetes
Diabetes specific nutritional product
Diabetes specific experimental nutritional product
once during crossover
once during crossover
Hospital Clinico San Carlos
Madrid, 28040, Spain
Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
Hospital Universitario Miguel Servet
Zaragoza, 50009, Spain
Jennifer Williams, MS
Abbott Nutrition
58 participants (actual enrollment reported by the registry).
First Submitted
November 23, 2008
First Posted
November 25, 2008
Study Start
November 2008
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
once during crossover
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
February 2009
Actual (reported)Study Completion
July 2009
Actual (reported)Last Updated
July 30, 2010
Record last verified: 2010-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: